Point72
Funding rounds backed by Point72.
- Funding disclosed in full
- $3.3B
- Median round
- $1B
- Rounds in calculation
- 3
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Valar Atomics Builds small modular nuclear reactors for AI data centers and industrial power | $1BSeries B | Climate techUnited States | |||
| Nscale Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference | $2BSeries C | AIUnited Kingdom | |||
| Mirador Therapeutics Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250MSeries B | BiotechUnited States | 17 participantsAdage Capital Partners L.P.ARCH Venture PartnersBlue Owl Healthcare OpportunitiesBoxer CapitalFairmountFarallon Capital ManagementFidelity Management & Research CompanyInc.InvusLogos CapitalMoore Strategic VenturesOrbiMedPoint72TCGXT. Rowe Price Investment ManagementVenrock Healthcare Capital PartnersWoodline Partners LP |